MEG3 could induce G0/G1 cell cycle arrest in glioma and ovarian cancer cells by inactivating the Wnt/β-catenin signaling pathway and upregulating PTEN expression, respectively [60,81]. This evidence concerns the gene MEG3 and central nervous system cancer.